Canal Capital Management, LLC Exact Sciences Corp Transaction History

Canal Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$57.56 - $82.54 $676,502 - $970,092	-11,753 Closed	0 $0
Q4 2021 Jan 27, 2022	SELL	$72.5 - $100.68 $137,605 - $191,090	-1,898 Reduced 13.9%	11,753 $915,000
Q3 2021 Oct 14, 2021	BUY	$90.24 - $124.05 $126,245 - $173,545	1,399 Added 11.42%	13,651 $1.3 Million
Q2 2021 Jul 14, 2021	BUY	$93.66 - $139.27 $123,724 - $183,975	1,321 Added 12.08%	12,252 $1.52 Million
Q1 2021 Apr 20, 2021	BUY	$116.57 - $155.01 $36,369 - $48,363	312 Added 2.94%	10,931 $1.44 Million
Q4 2020 Jan 27, 2021	SELL	$99.61 - $142.12 $17,929 - $25,581	-180 Reduced 1.67%	10,619 $1.41 Million
Q3 2020 Oct 21, 2020	BUY	$72.92 - $102.01 $787,463 - $1.1 Million	10,799 New	10,799 $1.1 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Canal Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Canal Capital Management, LLC with notifications on news.